Dmitry Balyasny’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.29M Buy
+2,684,000
New +$11.3M 0.01% 1119
2026
Q1
– Sell
-256,500
Closed -$1.28M – 3279
2025
Q4
$1.28M Buy
256,500
+71,200
+38% +$371K ﹤0.01% 2074
2025
Q3
$939K Buy
185,300
+28,000
+18% +$123K ﹤0.01% 2142
2025
Q2
$678K Buy
+157,300
New +$777K ﹤0.01% 2185
2025
Q1
– Sell
-19,200
Closed -$75.8K – 3117
2024
Q4
$75.8K Hold
19,200
– – ﹤0.01% 2622
2024
Q3
$112K Sell
19,200
-23,500
-55% -$116K ﹤0.01% 2627
2024
Q2
$184K Buy
+42,700
New +$205K ﹤0.01% 2350

Other funds holding MPT

Dmitry Balyasny's MPT Position: Q3 2026 in Review

Dmitry Balyasny increased its Medical Properties Trust (MPT) stake by 295% in Q3 2026, buying an estimated $6.69M and bringing the position to 2,129,887 shares worth $7.37M. The position accounts for 0.01% of the portfolio, ranked #1237.

Dmitry Balyasny first reported a position in MPT in Q3 2015 and has held it in 33 quarters since. The position peaked at $84.3M in Q4 2022. 459 funds tracked by Wall St. Rank hold MPT as of Q3 2026.

  • Dmitry Balyasny held 2,129,887 shares of Medical Properties Trust worth $7.37M as of Q3 2026.
  • Dmitry Balyasny bought 1,591,054 Medical Properties Trust shares in Q3 2026, an estimated $6.69M.
  • Medical Properties Trust made up 0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #1237 holding.
  • Dmitry Balyasny first reported a position in Medical Properties Trust in Q3 2015 and has held it in 33 quarters since.
  • Dmitry Balyasny's Medical Properties Trust position peaked at $84.3M in Q4 2022.
  • 459 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.